Advertisement
Advertisement
Flutizal

Flutizal

salmeterol + fluticasone

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Per 25 mcg/125 mcg actuation Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per 25 mcg/250 mcg actuation Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg
Indications/Uses
Asthma where use of combination (long acting β2-agonist & inhaled corticosteroid) is appropriate: Patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short-acting β2-agonist or those already controlled on both inhaled corticosteroids & long-acting β2-agonist.
Dosage/Direction for Use
Adult & adolescent ≥12 yr 2 inhalations (puffs) bid.
Contraindications
Special Precautions
Patients w/ active or quiescent pulmonary TB; thyrotoxicosis. Reduction in growth velocity (in childn). Pregnancy & lactation.
Adverse Reactions
Salmeterol: Tremor, subjective palpitations, headache. Fluticasone: Hoarseness, candidiasis of the mouth & throat; cutaneous hypersensitivity reactions.
Drug Interactions
Increased systemic exposure w/ strong CYP3A4 inhibitors (eg, ketoconazole, ritonavir).
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Flutizal 25 mcg/125 mcg MDI
Packing/Price
120 actuation x 1's (P411.6/box)
Form
Flutizal 25 mcg/250 mcg MDI
Packing/Price
120 actuation x 1's (P611.52/box)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement